APO Research
Talk to an analyst

APO RESEARCH · REPORT

Steroids

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Steroids Market Outlook and Growth Opportunities 2026

22 December 2025190 pages

Choose your research edition.

Industry ResearchSteroids Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Steroids Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Steroids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Steroids Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Steroids Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Steroids market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Steroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Steroids market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Steroids market include Zizhu Pharma, Sanofi, Novartis, Merck, Pfizer, GSK, Bayer, AstraZeneca and Sumitomo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Steroids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Steroids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Steroids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Steroids market size, projected growth trends, production technologies, key applications, and end-use industries.

Steroids Segment by Company

Zizhu Pharma

Sanofi

Novartis

Merck

Pfizer

GSK

Bayer

AstraZeneca

Sumitomo

Cipla

Steroids Segment by Type

Corticosteroids

Sex Hormones

Steroids Segment by Application

Injection

Inhalation

Oral

Topical

Steroids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Steroids status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Steroids market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Steroids significant trends, drivers, influence factors in global and regions.

6. To analyze Steroids competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Steroids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Steroids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Steroids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Steroids market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Steroids industry.

Chapter 3: Detailed analysis of Steroids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Steroids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Steroids in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Steroids Industry Trends Table 2. Steroids Industry Drivers Table 3. Steroids Industry Opportunities and Challenges Table 4. Steroids Industry Restraints Table 5. Global Steroids Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Steroids Revenue Share by Company (2021-2026) Table 7. Global Steroids Sales Volume by Company (k units) & (2021-2026) Table 8. Global Steroids Sales Volume Share by Company (2021-2026) Table 9. Global Steroids Average Price (US$/unit) of Company (2021-2026) Table 10. Global Steroids Company Ranking, (2024-2026) & (USD Million) Table 11. Global Steroids Key Company Manufacturing Base & Headquarters Table 12. Global Steroids Company, Product Type & Application Table 13. Global Steroids Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Steroids by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Corticosteroids Table 18. Significant Companies of Sex Hormones Table 19. Global Steroids Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Steroids Sales Volume by Type (2021-2026) & (k units) Table 21. Global Steroids Sales Volume by Type (2027-2032) & (k units) Table 22. Global Steroids Sales Volume Share by Type (2021-2026) Table 23. Global Steroids Sales Volume Share by Type (2027-2032) Table 24. Global Steroids Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Steroids Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Steroids Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Steroids Sales Value Share by Type (2021-2026) Table 28. Global Steroids Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Injection Table 30. Significant Companies of Inhalation Table 31. Significant Companies of Oral Table 32. Significant Companies of Topical Table 33. Global Steroids Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Steroids Sales Volume by Application (2021-2026) & (k units) Table 35. Global Steroids Sales Volume by Application (2027-2032) & (k units) Table 36. Global Steroids Sales Volume Share by Application (2021-2026) Table 37. Global Steroids Sales Volume Share by Application (2027-2032) Table 38. Global Steroids Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Steroids Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Steroids Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Steroids Sales Value Share by Application (2021-2026) Table 42. Global Steroids Sales Value Share by Application (2027-2032) Table 43. Global Steroids Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Steroids Sales by Region (2021-2026) & (k units) Table 45. Global Steroids Sales Market Share by Region (2021-2026) Table 46. Global Steroids Sales by Region (2027-2032) & (k units) Table 47. Global Steroids Sales Market Share by Region (2027-2032) Table 48. Global Steroids Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Steroids Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Steroids Sales Value Share by Region (2021-2026) Table 51. Global Steroids Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Steroids Sales Value Share by Region (2027-2032) Table 53. Global Steroids Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Steroids Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Steroids Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Steroids Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Steroids Sales by Country (2021-2026) & (k units) Table 58. Global Steroids Sales Market Share by Country (2021-2026) Table 59. Global Steroids Sales by Country (2027-2032) & (k units) Table 60. Global Steroids Sales Market Share by Country (2027-2032) Table 61. Global Steroids Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Steroids Sales Value Market Share by Country (2021-2026) Table 63. Global Steroids Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Steroids Sales Value Market Share by Country (2027-2032) Table 65. Zizhu Pharma Company Information Table 66. Zizhu Pharma Business Overview Table 67. Zizhu Pharma Steroids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Zizhu Pharma Steroids Product Portfolio Table 69. Zizhu Pharma Recent Development Table 70. Sanofi Company Information Table 71. Sanofi Business Overview Table 72. Sanofi Steroids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Sanofi Steroids Product Portfolio Table 74. Sanofi Recent Development Table 75. Novartis Company Information Table 76. Novartis Business Overview Table 77. Novartis Steroids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Novartis Steroids Product Portfolio Table 79. Novartis Recent Development Table 80. Merck Company Information Table 81. Merck Business Overview Table 82. Merck Steroids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Merck Steroids Product Portfolio Table 84. Merck Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Steroids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Pfizer Steroids Product Portfolio Table 89. Pfizer Recent Development Table 90. GSK Company Information Table 91. GSK Business Overview Table 92. GSK Steroids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. GSK Steroids Product Portfolio Table 94. GSK Recent Development Table 95. Bayer Company Information Table 96. Bayer Business Overview Table 97. Bayer Steroids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Bayer Steroids Product Portfolio Table 99. Bayer Recent Development Table 100. AstraZeneca Company Information Table 101. AstraZeneca Business Overview Table 102. AstraZeneca Steroids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. AstraZeneca Steroids Product Portfolio Table 104. AstraZeneca Recent Development Table 105. Sumitomo Company Information Table 106. Sumitomo Business Overview Table 107. Sumitomo Steroids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Sumitomo Steroids Product Portfolio Table 109. Sumitomo Recent Development Table 110. Cipla Company Information Table 111. Cipla Business Overview Table 112. Cipla Steroids Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Cipla Steroids Product Portfolio Table 114. Cipla Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Steroids Distributors List Table 118. Steroids Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Steroids Product Image Figure 2. Global Steroids Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Steroids Sales Value (2021-2032) & (US$ Million) Figure 4. Global Steroids Sales (2021-2032) & (k units) Figure 5. Global Steroids Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Steroids Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Corticosteroids Image Figure 10. Sex Hormones Image Figure 11. Global Steroids Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Steroids Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Steroids Sales Volume Share by Type (2021-2032) Figure 14. Global Steroids Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Steroids Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Steroids Sales Value Share by Type (2021-2032) Figure 17. Injection Image Figure 18. Inhalation Image Figure 19. Oral Image Figure 20. Topical Image Figure 21. Global Steroids Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Steroids Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Steroids Sales Volume Share by Application (2021-2032) Figure 24. Global Steroids Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Steroids Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Steroids Sales Value Share by Application (2021-2032) Figure 27. Global Steroids Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Steroids Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Steroids Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Steroids Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Steroids Sales Value (2021-2032) & (US$ Million) Figure 32. North America Steroids Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Steroids Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Steroids Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Steroids Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Steroids Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Steroids Sales Value (2021-2032) & (US$ Million) Figure 38. South America Steroids Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Steroids Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Steroids Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Steroids Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Steroids Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Steroids Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Steroids Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Steroids Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Corticosteroids
  • Sex Hormones
Applications
  • Injection
  • Inhalation
  • Oral
  • Topical
Companies covered
  • Zizhu Pharma
  • Sanofi
  • Novartis
  • Merck
  • Pfizer
  • GSK
  • Bayer
  • AstraZeneca
  • Sumitomo
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Steroids Sales Value (2021-2032)
  4. 1.2.2 Global Steroids Sales Volume (2021-2032)
  5. 1.2.3 Global Steroids Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Steroids Market Dynamics
  1. 2.1 Steroids Industry Trends
  2. 2.2 Steroids Industry Drivers
  3. 2.3 Steroids Industry Opportunities and Challenges
  4. 2.4 Steroids Industry Restraints
3 Steroids Market by Company
  1. 3.1 Global Steroids Company Revenue Ranking in 2025
  2. 3.2 Global Steroids Revenue by Company (2021-2026)
  3. 3.3 Global Steroids Sales Volume by Company (2021-2026)
  4. 3.4 Global Steroids Average Price by Company (2021-2026)
  5. 3.5 Global Steroids Company Ranking (2024-2026)
  6. 3.6 Global Steroids Company Manufacturing Base and Headquarters
  7. 3.7 Global Steroids Company Product Type and Application
  8. 3.8 Global Steroids Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Steroids Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Steroids Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Steroids Market by Type
  1. 4.1 Steroids Type Introduction
  2. 4.1.1 Corticosteroids
  3. 4.1.2 Sex Hormones
  4. 4.2 Global Steroids Sales Volume by Type
  5. 4.2.1 Global Steroids Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Steroids Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Steroids Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Steroids Sales Value by Type
  9. 4.3.1 Global Steroids Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Steroids Sales Value by Type (2021-2032)
  11. 4.3.3 Global Steroids Sales Value Share by Type (2021-2032)
5 Steroids Market by Application
  1. 5.1 Steroids Application Introduction
  2. 5.1.1 Injection
  3. 5.1.2 Inhalation
  4. 5.1.3 Oral
  5. 5.1.4 Topical
  6. 5.2 Global Steroids Sales Volume by Application
  7. 5.2.1 Global Steroids Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Steroids Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Steroids Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Steroids Sales Value by Application
  11. 5.3.1 Global Steroids Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Steroids Sales Value by Application (2021-2032)
  13. 5.3.3 Global Steroids Sales Value Share by Application (2021-2032)
6 Steroids Regional Sales and Value Analysis
  1. 6.1 Global Steroids Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Steroids Sales by Region (2021-2032)
  3. 6.2.1 Global Steroids Sales by Region: 2021-2026
  4. 6.2.2 Global Steroids Sales by Region (2027-2032)
  5. 6.3 Global Steroids Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Steroids Sales Value by Region (2021-2032)
  7. 6.4.1 Global Steroids Sales Value by Region: 2021-2026
  8. 6.4.2 Global Steroids Sales Value by Region (2027-2032)
  9. 6.5 Global Steroids Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Steroids Sales Value (2021-2032)
  12. 6.6.2 North America Steroids Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Steroids Sales Value (2021-2032)
  15. 6.7.2 Europe Steroids Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Steroids Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Steroids Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Steroids Sales Value (2021-2032)
  21. 6.9.2 South America Steroids Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Steroids Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Steroids Sales Value Share by Country, 2025 VS 2032
7 Steroids Country-level Sales and Value Analysis
  1. 7.1 Global Steroids Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Steroids Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Steroids Sales by Country (2021-2032)
  4. 7.3.1 Global Steroids Sales by Country (2021-2026)
  5. 7.3.2 Global Steroids Sales by Country (2027-2032)
  6. 7.4 Global Steroids Sales Value by Country (2021-2032)
  7. 7.4.1 Global Steroids Sales Value by Country (2021-2026)
  8. 7.4.2 Global Steroids Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Steroids Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Steroids Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Steroids Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Steroids Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Steroids Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Steroids Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Steroids Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Steroids Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Steroids Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Steroids Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Steroids Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Steroids Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Steroids Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Steroids Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Steroids Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Steroids Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Steroids Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Steroids Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Steroids Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Steroids Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Steroids Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Steroids Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Steroids Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Steroids Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Steroids Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Steroids Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Steroids Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Steroids Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Steroids Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Steroids Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Steroids Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Steroids Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Steroids Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Steroids Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Steroids Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Steroids Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Steroids Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Steroids Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Steroids Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Steroids Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Steroids Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Steroids Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Steroids Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Steroids Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Steroids Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Steroids Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Steroids Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Steroids Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Steroids Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Steroids Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Steroids Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Steroids Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Steroids Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Steroids Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Steroids Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Steroids Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Steroids Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Steroids Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Steroids Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Steroids Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Steroids Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Steroids Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Steroids Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Steroids Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Steroids Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Steroids Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Steroids Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Steroids Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Steroids Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Steroids Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Steroids Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Steroids Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Steroids Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Steroids Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Steroids Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Steroids Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Steroids Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Steroids Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Steroids Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Steroids Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Steroids Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Steroids Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Steroids Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Steroids Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zizhu Pharma
  2. 8.1.1 Zizhu Pharma Company Information
  3. 8.1.2 Zizhu Pharma Business Overview
  4. 8.1.3 Zizhu Pharma Steroids Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zizhu Pharma Steroids Product Portfolio
  6. 8.1.5 Zizhu Pharma Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Steroids Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Steroids Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Steroids Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Steroids Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Steroids Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Steroids Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Steroids Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Steroids Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Steroids Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GSK Steroids Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Steroids Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Steroids Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 AstraZeneca
  44. 8.8.1 AstraZeneca Company Information
  45. 8.8.2 AstraZeneca Business Overview
  46. 8.8.3 AstraZeneca Steroids Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 AstraZeneca Steroids Product Portfolio
  48. 8.8.5 AstraZeneca Recent Developments
  49. 8.9 Sumitomo
  50. 8.9.1 Sumitomo Company Information
  51. 8.9.2 Sumitomo Business Overview
  52. 8.9.3 Sumitomo Steroids Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sumitomo Steroids Product Portfolio
  54. 8.9.5 Sumitomo Recent Developments
  55. 8.10 Cipla
  56. 8.10.1 Cipla Company Information
  57. 8.10.2 Cipla Business Overview
  58. 8.10.3 Cipla Steroids Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cipla Steroids Product Portfolio
  60. 8.10.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Steroids Value Chain Analysis
  2. 9.1.1 Steroids Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Steroids Sales Mode & Process
  6. 9.2 Steroids Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Steroids Distributors
  9. 9.2.3 Steroids Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst